These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8862166)

  • 1. A method to measure the costs of counseling for HIV prevention.
    Gorsky RD
    Public Health Rep; 1996; 111 Suppl 1(Suppl 1):115-22. PubMed ID: 8862166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of HIV infection in drug abusers: a cost analysis.
    Gorsky RD; MacGowan RJ; Swanson NM; DelGado BP
    Prev Med; 1995 Jan; 24(1):3-8. PubMed ID: 7740013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus counseling, testing, referral, and partner notification services. A cost-benefit analysis.
    Holtgrave DR; Valdiserri RO; Gerber AR; Hinman AR
    Arch Intern Med; 1993 May; 153(10):1225-30. PubMed ID: 8388208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
    Holtgrave DR
    J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost and efficiency of HIV voluntary counselling and testing centres in Andhra Pradesh, India.
    Dandona L; Sisodia P; Ramesh YK; Kumar SG; Kumar AA; Rao MC; Someshwar M; Hansl B; Marshall N; Marseille E; Kahn JG
    Natl Med J India; 2005; 18(1):26-31. PubMed ID: 15835489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?
    Phillips KA; Hotlgrave DR
    Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equivalence of two healthcare costing methods: bottom-up and top-down.
    Chapko MK; Liu CF; Perkins M; Li YF; Fortney JC; Maciejewski ML
    Health Econ; 2009 Oct; 18(10):1188-201. PubMed ID: 19097041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.
    Krentz HB; Auld MC; Gill MJ;
    CMAJ; 2003 Jul; 169(2):106-10. PubMed ID: 12874156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda.
    Gafni A; Birch S
    Soc Sci Med; 2006 May; 62(9):2091-100. PubMed ID: 16325975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unit cost of counseling and patients length of stay in a residential drug treatment setting.
    Alemi F; Haack M; Holifield L; Claudio Y; Haqqi K
    J Ment Health Policy Econ; 2002 Sep; 5(3):103-7. PubMed ID: 12728196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining true nursing costs improves financial planning.
    Payson AA
    Health Prog; 1987 May; 68(4):50-1, 80. PubMed ID: 10312018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of alternative staff time data collection methods on drug treatment service cost estimates.
    Zarkin GA; Dunlap LJ; Wedehase B; Cowell AJ
    Eval Program Plann; 2008 Nov; 31(4):427-35. PubMed ID: 18640722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The business of radiology: cost accounting.
    Camponovo EJ
    J Am Coll Radiol; 2004 Aug; 1(8):567-75. PubMed ID: 17411655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incremental cost effectiveness of multifocal cataract surgery].
    Pagel N; Dick HB; Krummenauer F
    Klin Monbl Augenheilkd; 2007 Feb; 224(2):101-9. PubMed ID: 17309005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Collection and elaboration of the economic information necessary for calculating the costs of therapeutic decisions].
    Viens-Bitker C; Leclercq B
    Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():49-53. PubMed ID: 2512888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The economic costs in the production of health services: from the cost of inputs to the cost of case management].
    Arredondo A; Damián T
    Salud Publica Mex; 1997; 39(2):117-24. PubMed ID: 9254435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY; Billah K; Lieu TA; Weinstein MC
    Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.